This inconsistency could be attributed to a higher proportion of infiltrative cases in the GNAS wild-type cohort (53%, 11/21) than in the mutation cohort (43%, 17/40), while infiltration is an important factor that affects the prognosis of IPMN patients. This evidence concerns the gene GNAS and pancreatic intraductal papillary-mucinous neoplasm.